Hobart Kalkstein - 19 Aug 2024 Form 4 Insider Report for CABOT CORP (CBT)

Role
Executive Vice President
Signature
By: Jennifer Lombardi, pursuant to a power of attorney from Hobart C. Kalkstein
Issuer symbol
CBT
Transactions as of
19 Aug 2024
Net transactions value
-$1,216,217
Form type
4
Filing time
21 Aug 2024, 17:00:03 UTC
Previous filing
18 Jun 2024
Next filing
17 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBT Common Stock Options Exercise $608,937 +14,863 +24% $40.97 76,551 19 Aug 2024 Direct
transaction CBT Common Stock Sale $1,499,848 -14,863 -19% $100.91 61,688 19 Aug 2024 Direct F1
transaction CBT Common Stock Options Exercise $179,408 +4,379 +7.1% $40.97 66,067 20 Aug 2024 Direct
transaction CBT Common Stock Sale $441,986 -4,379 -6.6% $100.93 61,688 20 Aug 2024 Direct F2
transaction CBT Common Stock Options Exercise $44,166 +1,078 +1.7% $40.97 62,766 20 Aug 2024 Direct
transaction CBT Common Stock Sale $106,894 -1,078 -1.7% $99.16 61,688 20 Aug 2024 Direct
holding CBT Common Stock 7,121 19 Aug 2024 Through the Trustee for the Corporation's 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBT Employee Stock Option (Right to Buy) Options Exercise $0 -14,863 -73% $0.000000 5,457 19 Aug 2024 Common Stock 14,863 $40.97 Direct F3
transaction CBT Employee Stock Option (Right to Buy) Options Exercise $0 -4,379 -80% $0.000000 1,078 20 Aug 2024 Common Stock 4,379 $40.97 Direct F3
transaction CBT Employee Stock Option (Right to Buy) Options Exercise $0 -1,078 -100% $0.000000 0 20 Aug 2024 Common Stock 1,078 $40.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.900 to $100.985, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
F2 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.900 to $101.000, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
F3 32,507 shares were subject to the option. The option vested over a three year period as follows: 30% on November 13, 2021, 30% on November 13, 2022 and 40% on November 13, 2023.